EP0236329A1 - Aminosalicylsäurederivate und pharmazeutische zusammensetzungen - Google Patents

Aminosalicylsäurederivate und pharmazeutische zusammensetzungen

Info

Publication number
EP0236329A1
EP0236329A1 EP86900097A EP86900097A EP0236329A1 EP 0236329 A1 EP0236329 A1 EP 0236329A1 EP 86900097 A EP86900097 A EP 86900097A EP 86900097 A EP86900097 A EP 86900097A EP 0236329 A1 EP0236329 A1 EP 0236329A1
Authority
EP
European Patent Office
Prior art keywords
amino
hydroxy
benzoic acid
formula
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP86900097A
Other languages
English (en)
French (fr)
Inventor
Giancarlo Sportoletti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ITAL-FARMACO SpA
Italfarmaco SpA
Original Assignee
ITAL-FARMACO SpA
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ITAL-FARMACO SpA, Italfarmaco SpA filed Critical ITAL-FARMACO SpA
Publication of EP0236329A1 publication Critical patent/EP0236329A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Definitions

  • the residue is taken up with 100 ml of acetone and 10 ml of water, 0.68 g of imidazole base are added and the mixture is stirred overnight. After solvent evaporation under reduced pressure, the residue is treated with ethyl acetate. The organic phase is washed with water, diluted hydrochloric acid- and water to neutrality. After drying on sodium sul- phate and filtration, the solvent is evaporated under vacuum. The residue is crystallized from ethanol/water. Yield: 28 g (72%) .
  • the test has been performed according to Di Rosa et al. (Di Rosa M. , Giround J.P., Willoughby D.A. - J. Path. Bact., vol. 104, 15, 1971).
  • a 1% solution (0.15 ml) of carrageenin in 0.9% NaCl was injected into the pleural cavity of Sprague-Dawley rats, weighing about 250 g.
  • the animals were sacrificed, the pleural exudate volumes were measured and the leukocytes total number was counted by a micro- cell-counter, being the cavity rinsed by 0.5 ml of a sali- ne medium.
  • the % inhibition of leukocytes total number was calcu ⁇ lated versus control animals.
  • the assayed compounds were administered orally, 1 mM/kg, 30' before the carrageenin injection in the pleural cavity.
  • Table IV as not limi ⁇ ting example, the results obtained with some of the compo ⁇ unds of the invention are reported.
  • the assay has been performed according to Gemmel et al. (Gemmel D.K. Cottney J., Lewis A.J. - Agents Actions, vol. 9, 107, 1979). 1 Ml of a rabbit anti-bovine-albumin serum (freeze-dried antibodies, dissolved in 2 ml of 0.9% NaCl) was injected into the caudal vena of Sprague-Dawley male rats.
  • the assay has been performed according to Sharon (Sharon P., Stenson W.F. - Gastroenterology, vol. 88, 55, 1985) .
  • the administered doses (via intra-bowel, during the bowel ligature and the local injection of the acetic acid) were 0.5 mM/kg, for all the tested compounds, dispersed" in carboxymethylcellulose. The % reduction of the ulceration index has been calculated versus untreated animals.
  • the compounds of Table 1 have been subjected to the acute toxicity test in mice, by the oral route, in carbo ⁇ xymethylcellulose suspensions. All the LD proved to be higher than 1600 mg/kg.
  • the doses will be dependent on the patient's weight, age and conditions and will be anyhow ranging from 50 to 1000 mg, from 1 to 4 times a day.
EP86900097A 1984-11-29 1985-11-26 Aminosalicylsäurederivate und pharmazeutische zusammensetzungen Withdrawn EP0236329A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23799/84A IT1196348B (it) 1984-11-29 1984-11-29 Composti ad attivita'antiinfiammatoria
IT2379984 1984-11-29

Publications (1)

Publication Number Publication Date
EP0236329A1 true EP0236329A1 (de) 1987-09-16

Family

ID=11210091

Family Applications (1)

Application Number Title Priority Date Filing Date
EP86900097A Withdrawn EP0236329A1 (de) 1984-11-29 1985-11-26 Aminosalicylsäurederivate und pharmazeutische zusammensetzungen

Country Status (12)

Country Link
EP (1) EP0236329A1 (de)
JP (1) JPS62501703A (de)
KR (1) KR870700608A (de)
CN (1) CN85109554A (de)
AU (1) AU5231186A (de)
DK (1) DK346486A (de)
ES (1) ES8701717A1 (de)
GR (1) GR852834B (de)
IT (1) IT1196348B (de)
PT (1) PT81566B (de)
WO (1) WO1986003199A1 (de)
ZA (1) ZA859035B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017710D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
GB9017711D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
IT1244873B (it) * 1990-09-12 1994-09-12 Depha Team Srl Derivati dell'acido 5-aminosalicilico (5-asa) per la terapia delle infiammazioni croniche intestinali
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
FR2738150B1 (fr) * 1995-09-01 1997-10-31 Synthelabo Utilisation de la sulphasalazine et de ses metabolites pour la fabrication d'un medicament utile dans le traitement de l'insuffisance veineuse et des ulceres veineux
EP1274675B1 (de) * 2000-04-19 2004-09-01 Neurotech Co., Ltd. Verbindungen, zusammensetzungen und verfahren zur vorbeugung der neurodegeneration bei akuten oder chronischen verletzungen des zentralen nervensystems
US6573402B1 (en) 2000-04-20 2003-06-03 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
NO20013534L (no) * 2000-07-18 2002-01-21 Koyo Chemical Company Ltd Anvendelse av en blanding omfattende et glucosaminsalt eller et glucosaminderivat for fremstilling av et medikament for behandling av human trombose
ATE412174T1 (de) 2001-01-19 2008-11-15 Apex Biotechnology Corp Nicht-enzymatischer, detergenzien enthaltender einweg-elektrodestreifen für den nachweis von harnsäure oder hämoglobin,sowie verfahren für die produktion und anwendung desgleichen
KR20040048411A (ko) 2001-09-14 2004-06-09 메틸진, 인크. 히스톤 데아세틸라아제의 억제제
AU2003245070C1 (en) 2002-06-19 2008-02-28 GNT Pharma Co., Ltd Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
KR100668111B1 (ko) 2005-07-28 2007-01-12 (주)에스에이치제약 강력한 항산화 효과를 가짐으로써 급성 및 퇴행성 뇌신경계질환의 예방 및 치료에 이용 가능한 신규물질인아미노살리실산 유도체와 그 염의 제조방법
JP5450053B2 (ja) 2006-04-13 2014-03-26 ニューロテック ファーマシューティカルズ カンパニー リミテッド 細胞損傷及び炎症疾患の治療または予防用薬学組成物
CN100422721C (zh) * 2006-05-26 2008-10-01 南京大学 一种利用糖基萘酚的铝离子检测方法
EP2201946A4 (de) * 2007-10-23 2012-01-25 Inst Med Molecular Design Inc Hemmer der pai-1-produktion
KR100852962B1 (ko) 2007-11-12 2008-08-20 주식회사 뉴로테크 2-하이드록시-5-페닐알킬아미노벤조산 유도체 및 이의 염의제조방법
ES2656903T3 (es) 2008-07-08 2018-02-28 Catabasis Pharmaceuticals, Inc. Salicilatos acetilados de ácidos grasos y sus usos
US9085527B2 (en) 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
KR101204108B1 (ko) * 2009-02-09 2012-11-22 주식회사 지엔티파마 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도
SG178948A1 (en) 2009-09-01 2012-04-27 Catabasis Pharmaceuticals Inc Fatty acid niacin conjugates and their uses
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
SG11201407319YA (en) * 2012-05-23 2014-12-30 Cellix Bio Private Ltd Compositions and methods for treatment of inflammatory bowel disease
WO2014070859A1 (en) * 2012-10-30 2014-05-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Stat3 dimerization inhibitors
CA3124767A1 (en) * 2018-12-28 2020-07-02 Gnt Pharma Co., Ltd. Compositions and methods for treating neurodegenerative disorders
CN111116395B (zh) * 2019-12-27 2023-04-07 湖北工业大学 多碘代芳香酸类化合物及其在抗腺病毒7型中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4546M (de) * 1964-06-09 1966-11-02
NL7008623A (de) * 1969-06-25 1970-12-29
JPS5640710B2 (de) * 1973-01-18 1981-09-22
JPS6056130B2 (ja) * 1978-03-20 1985-12-09 久光製薬株式会社 新規なサリチル酸誘導体
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8603199A1 *

Also Published As

Publication number Publication date
KR870700608A (ko) 1987-12-30
AU5231186A (en) 1986-06-18
IT1196348B (it) 1988-11-16
PT81566A (en) 1985-12-01
ZA859035B (en) 1986-08-27
PT81566B (en) 1987-04-07
CN85109554A (zh) 1986-07-23
GR852834B (de) 1986-03-27
WO1986003199A1 (en) 1986-06-05
ES8701717A1 (es) 1986-12-01
IT8423799A0 (it) 1984-11-29
DK346486D0 (da) 1986-07-21
DK346486A (da) 1986-07-21
ES549359A0 (es) 1986-12-01
JPS62501703A (ja) 1987-07-09

Similar Documents

Publication Publication Date Title
EP0236329A1 (de) Aminosalicylsäurederivate und pharmazeutische zusammensetzungen
US4443475A (en) Amides of acyl-carnitines, process for preparing same and pharmaceutical compositions containing such amides
KR100343243B1 (ko) 항-염증성및/또는진통성활성을가지는니트릭에스테르들과그제조방법
JPS595196A (ja) ホスフイニルアルカノイル置換プロリン類のエステル
CA1334972C (en) Pyridine-2,4- and -2,5-dicarboxylic acid amides, processes for their preparation, the use thereof, and medicaments based on these compounds
JPS59139357A (ja) アミジン誘導体
NL8002828A (nl) 2-(mercapto-1-oxoalkyl)-1,2,3,4-tetrahydroisochinoline- -3-carbonzuren en hun derivaten.
NL8903132A (nl) Capsaicinederivaten, werkwijzen voor hun bereiding, farmaceutische preparaten die ze bevatten en hun toepassing als farmaceutica.
US4096256A (en) 7-Acyl-3-(ureidoalkyl substituted tetrazolylthiomethyl) cephalosporins, antibacterial compositions containing them, and methods of treating bacterial infections using them
KR910000646A (ko) (아릴설폰아미도-및 피리딜-또는 이미다졸릴-) 치환된 카복실산 및 이의 유도체
US4496735A (en) Certain pyridyloxy-or-thio-phenyl propenoic acid derivatives
JPS63216872A (ja) 複素環式化合物
US4510142A (en) Derivatives of biphenyl alkyl carboxylates and their use as medicaments
JPS5829950B2 (ja) 環状イミノカルボン酸誘導体およびその塩類
IE60205B1 (en) Pharmaceutically useful derivatives of thiazolidine-4-carboxylic acid
CZ322092A3 (en) N-(alpha-substituted pyridinyl)carbonyl dipeptides, process of their preparation and pharmaceutical compositions based thereon
US4277496A (en) Methods of treating mammals suffering from inflammation and pain
US4478843A (en) 5-Phenyltetrazoles and their use as salidiuretics
US4273777A (en) Methods of treating mammals suffering from inflammation and pain
FI68622C (fi) Foerfarande foer framstaellning av indolaettiksyraderivat
US5364873A (en) Pyridine-2,4- and dicarboxylic acid derivatives, the use thereof and pharmaceutical composition based on these compounds
US4311699A (en) Aminoacid derivatives of cephalosporin compounds
FI77022C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara pyrrolaettiksyraderivat.
US3547948A (en) 4-amino-1,2-dithiolane-4-carboxylic acids
JPH05331164A (ja) アンジオテンシンii拮抗性イソインドール誘導体

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19870520

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19880816

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19881228

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SPORTOLETTI, GIANCARLO